Clinical Trials for Autoimmune Diseases of the Nervous System

Find clinical trials for autoimmune diseases of the nervous system. Discover research opportunities and treatment options in your area.

8 Active Trials Found

Showing 8 trials on this page

Page 1 of 1

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

NCT ID: NCT06626919

This clinical trial is studying a new treatment called anitocabtagene autoleucel (or anito-cel) for people with a condition known as generalized myasthenia gravis (GMG), which causes muscle weaknes...

Recruiting

Phase: PHASE1 Type: interventional Locations: Columbus, Ohio, United States, Philadelphia, Pennsylvania, United States +7 more

JY231 Injection for the Treatment of Relapsed/Refractory Neurologic Immune Disorders

NCT ID: NCT06797024

This clinical trial is exploring a new treatment called JY231 injection for patients who have certain autoimmune diseases affecting the nervous system and have not responded well to other treatment...

Recruiting

Phase: NA Type: interventional Locations: Wuhan, Hubei, China

Biomarkers in Autoimmune Disease of Nervous System

NCT ID: NCT06502015

This clinical trial is looking at different autoimmune diseases that can affect the nervous system, such as Multiple Sclerosis, Myasthenia Gravis, and Neuromyelitis Optica Spectrum Disorder. These ...

Recruiting

Type: observational Locations: Wuhan, , China

Safety and Efficacy of Melatonin in Patients with Multiple Progressive Primary Sclerosis

NCT ID: NCT03540485

This clinical trial is studying the safety and effectiveness of melatonin, a natural hormone often used to improve sleep, in combination with a medication called ocrelizumab for patients with Progr...

Recruiting

Phase: PHASE1 Type: interventional Locations: Seville, , Spain, Seville, , Spain +1 more

Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System

NCT ID: NCT04561557

This clinical trial is studying a new treatment called CT103A cells for patients with certain autoimmune diseases that affect the nervous system. These diseases include conditions like Myasthenia G...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Wuhan, Hubei, China

Predictors and Prognostic Factors of Myasthenia Gravis Outcome

NCT ID: NCT05214612

This clinical trial is studying a condition called Myasthenia Gravis (MG), which affects the nervous system and can cause muscle weakness. The goal of the study is to better understand the differen...

Recruiting

Type: observational Locations: Assiut, , Egypt

Acceptability of Exoskeleton Assisted Walking for Persons With Mobility Issues Due to Multiple Sclerosis

NCT ID: NCT04786821

This clinical trial is studying the use of a powered Exoskeleton to help people with multiple sclerosis (MS) who have difficulty walking. The Exoskeleton is a wearable robotic device that can assis...

Recruiting

Phase: NA Type: interventional Locations: Sheffield, South Yorkshire, United Kingdom

Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS

NCT ID: NCT05834855

This clinical trial is comparing two medications, rituximab and ocrelizumab, to see if rituximab is just as effective and safe for treating relapsing multiple sclerosis (RMS) as ocrelizumab. Ocreli...

Recruiting

Phase: PHASE3 Type: interventional Locations: Amsterdam, , Netherlands

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions